Stock Information
Repligen Corp (RGEN)
Ticker Symbol: RGEN
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $7,246.31 mil
Piotroski score: 5
PE Ratio: 141.7783
EPS (TTM): 0.8644
Revenue (TTM): $13.02 M
Dividend Yield: N/A%
ROE: 2.37%
Latest News
-
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead
Tue, Mar 3, 2026 2:31 PM
-
3 Healthcare Stocks We’re Skeptical Of
Tue, Mar 3, 2026 1:51 PM
-
Baron Health Care Fund Q4 2025 Recent Activity
Tue, Mar 3, 2026 10:36 AM
-
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know
Sat, Feb 28, 2026 12:36 AM
-
UBS Maintains Buy on Repligen, Lowers Price Target to $195
Wed, Feb 25, 2026 4:22 PM
-
A Glimpse Into The Expert Outlook On Repligen Through 6 Analysts
Wed, Feb 25, 2026 4:00 PM
-
How The Repligen (RGEN) Narrative Is Shifting With New Targets M&A Plans And Products
Wed, Feb 25, 2026 2:11 PM
-
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Wed, Feb 25, 2026 2:10 PM
-
Barclays Maintains Overweight on Repligen, Lowers Price Target to $175
Wed, Feb 25, 2026 12:06 PM
-
Wells Fargo Maintains Overweight on Repligen, Lowers Price Target to $180
Wed, Feb 25, 2026 10:52 AM
Key Financials
Financial data not available
